Literature DB >> 29458727

Ineffective Erythropoiesis: Anemia and Iron Overload.

Ritama Gupta1, Khaled M Musallam2, Ali T Taher3, Stefano Rivella4.   

Abstract

Stress erythropoiesis (SE) is characterized by an imbalance in erythroid proliferation and differentiation under increased demands of erythrocyte generation and tissue oxygenation. β-thalassemia represents a chronic state of SE, called ineffective erythropoiesis (IE), exhibiting an expansion of erythroid-progenitor pool and deposition of alpha chains on erythrocyte membranes, causing cell death and anemia. Concurrently, there is a decrease in hepcidin expression and a subsequent state of iron overload. There are substantial investigative efforts to target increased iron absorption under IE. There are also avenues for targeting cell contact and signaling within erythroblastic islands under SE, for therapeutic benefits.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Erythroblastic island; Hepcidin and iron homeostasis; Iron overload; Stress and ineffective erythropoiesis

Mesh:

Substances:

Year:  2017        PMID: 29458727      PMCID: PMC5824437          DOI: 10.1016/j.hoc.2017.11.009

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  54 in total

1.  Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE.

Authors:  A P West; M J Bennett; V M Sellers; N C Andrews; C A Enns; P J Bjorkman
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

2.  Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.

Authors:  Mahta Nili; Ujwal Shinde; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.

Authors:  Jean-Benoît Arlet; Jean-Antoine Ribeil; Flavia Guillem; Olivier Negre; Adonis Hazoume; Guillaume Marcion; Yves Beuzard; Michaël Dussiot; Ivan Cruz Moura; Samuel Demarest; Isaure Chauvot de Beauchêne; Zakia Belaid-Choucair; Margaux Sevin; Thiago Trovati Maciel; Christian Auclair; Philippe Leboulch; Stany Chretien; Luba Tchertanov; Véronique Baudin-Creuza; Renaud Seigneuric; Michaela Fontenay; Carmen Garrido; Olivier Hermine; Geneviève Courtois
Journal:  Nature       Date:  2014-08-24       Impact factor: 49.962

Review 4.  Mechanisms of iron accumulation in hereditary hemochromatosis.

Authors:  Robert E Fleming; William S Sly
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

5.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 6.  Iron age: novel targets for iron overload.

Authors:  Carla Casu; Stefano Rivella
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

7.  An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Authors:  Paul J Schmidt; Iva Toudjarska; Anoop K Sendamarai; Tim Racie; Stuart Milstein; Brian R Bettencourt; Julia Hettinger; David Bumcrot; Mark D Fleming
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

8.  Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis.

Authors:  Jing Liu; Jianhua Zhang; Yelena Ginzburg; Huihui Li; Fumin Xue; Lucia De Franceschi; Joel Anne Chasis; Narla Mohandas; Xiuli An
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

9.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

10.  Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands.

Authors:  Y Sadahira; T Yoshino; Y Monobe
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  16 in total

1.  Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.

Authors:  Carla Casu; Mariateresa Pettinato; Alison Liu; Mariam Aghajan; Vania Lo Presti; Maria Rosa Lidonnici; Kevin A Munoz; Emir O'Hara; Violante Olivari; Simona Maria Di Modica; Sheri Booten; Shuling Guo; Garry Neil; Reem Miari; Nir Shapir; Inbal Zafir-Lavie; Hagit Domev; Giuliana Ferrari; Despina Sitara; Antonella Nai; Stefano Rivella
Journal:  Blood       Date:  2020-10-22       Impact factor: 22.113

Review 2.  Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.

Authors:  Stefano Rivella
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

3.  Therapy for lower-risk MDS.

Authors:  Hetty E Carraway; Caner Saygin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 4.  Iron imbalance in cancer: Intersection of deficiency and overload.

Authors:  Tulika Basak; Rupinder Kaur Kanwar
Journal:  Cancer Med       Date:  2022-04-22       Impact factor: 4.711

5.  Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin.

Authors:  Pei Jin Lim; Tiago L Duarte; João Arezes; Daniel Garcia-Santos; Amel Hamdi; Sant-Rayn Pasricha; Andrew E Armitage; Hema Mehta; Sarah Wideman; Ana G Santos; Andreia Santos-Gonçalves; Alireza Morovat; Jim R Hughes; Elizabeth Soilleux; Chia-Yu Wang; Abraham L Bayer; Paul Klenerman; Christian B Willberg; Richard C Hartley; Michael P Murphy; Jodie L Babitt; Prem Ponka; Graça Porto; Hal Drakesmith
Journal:  Nat Metab       Date:  2019-05-13

6.  Body weight and its influence on hepcidin levels in patients with type 2 diabetes: A systematic review and meta-analysis of clinical studies.

Authors:  Fransina Ndevahoma; Munyaradzi Mukesi; Phiwayinkosi V Dludla; Bongani B Nkambule; Elina P Nepolo; Tawanda M Nyambuya
Journal:  Heliyon       Date:  2021-03-11

7.  Relationship of Iron Metabolism and Short-Term Cuprizone Treatment of C57BL/6 Mice.

Authors:  Edina Pandur; Ramóna Pap; Edit Varga; Gergely Jánosa; Sámuel Komoly; Judit Fórizs; Katalin Sipos
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

8.  Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess.

Authors:  Courtney J Mercadante; Milankumar Prajapati; Jignesh H Parmar; Heather L Conboy; Miriam E Dash; Michael A Pettiglio; Carolina Herrera; Julia T Bu; Edward G Stopa; Pedro Mendes; Thomas B Bartnikas
Journal:  Haematologica       Date:  2018-11-08       Impact factor: 9.941

Review 9.  Hepcidin and Anemia: A Tight Relationship.

Authors:  Alessia Pagani; Antonella Nai; Laura Silvestri; Clara Camaschella
Journal:  Front Physiol       Date:  2019-10-09       Impact factor: 4.566

Review 10.  EnvIRONmental Aspects in Myelodysplastic Syndrome.

Authors:  Verena Petzer; Igor Theurl; Günter Weiss; Dominik Wolf
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.